• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性血液透析患儿的促红细胞生成素抵抗:一项横断面研究。

Erythropoietin resistance among pediatric patients on chronic hemodialysis: A cross-sectional study.

作者信息

Helmy Rasha, Fadel Fatina I, Galal Rasha E, Mohammed Amira M, Sayed Shaimaa

机构信息

Pediatric Department, Faculty of Medicine, Cairo University, 4 Extension of Nobar Street, Cairo, Egypt.

出版信息

Pediatr Nephrol. 2025 Apr 28. doi: 10.1007/s00467-025-06776-4.

DOI:10.1007/s00467-025-06776-4
PMID:40293460
Abstract

BACKGROUND

The erythropoietin resistance index (ERI) is an accurate indicator of erythropoietin (EPO) resistance and is related to a worse prognosis in patients on hemodialysis (HD). ERI is simple, cheap and could be calculated easily in children receiving HD. We aimed to assess the EPO resistance in children with kidney failure on regular HD.

METHODS

An analytical cross-sectional study was conducted on 80 children with kidney failure on regular HD. They were assessed by history taking and laboratory investigations including complete blood count, C- reactive protein (CRP), iron, ferritin, parathyroid hormone and serum electrolytes. ERI was calculated.

RESULTS

The study included 80 patients; 41 (51.2%) were male. The mean age of the study group was 8.86 ± 2.76 years. Sixty-three patients (78.8%) were on iron therapy. Mean ERI was 28.87 ± 10.62. The ERI was significantly positively correlated with age (r = 0.242; P = 0.031), EPO dose (r = 0.290; P = 0.001) and CRP (r = 0.219; P = 0.049). The ERI had a significantly negative correlation with KT/V (r = - 0.262; P = 0.019), hemoglobin level (r = - 0.265; P = 0.001) and platelet count (r = - 0.254; P = 0.023).

CONCLUSIONS

Erythropoietin resistance is associated with many risk factors, including high CRP and low KT/V. Inadequate HD is the most important risk factor for EPO resistance in children on chronic HD. Adequate HD is considered as a protective measure against EPO resistance.

摘要

背景

促红细胞生成素抵抗指数(ERI)是促红细胞生成素(EPO)抵抗的准确指标,且与血液透析(HD)患者的不良预后相关。ERI简单、廉价,在接受HD的儿童中易于计算。我们旨在评估规律HD治疗的肾衰竭儿童的EPO抵抗情况。

方法

对80例规律HD治疗的肾衰竭儿童进行了一项分析性横断面研究。通过病史采集和实验室检查对他们进行评估,包括全血细胞计数、C反应蛋白(CRP)、铁、铁蛋白、甲状旁腺激素和血清电解质。计算ERI。

结果

该研究纳入80例患者;41例(51.2%)为男性。研究组的平均年龄为8.86±2.76岁。63例患者(78.8%)接受铁剂治疗。平均ERI为28.87±10.62。ERI与年龄(r=0.242;P=0.031)、EPO剂量(r=0.290;P=0.001)和CRP(r=0.219;P=0.049)显著正相关。ERI与KT/V(r=-0.262;P=0.019)、血红蛋白水平(r=-0.265;P=0.001)和血小板计数(r=-0.254;P=0.023)显著负相关。

结论

促红细胞生成素抵抗与许多危险因素相关,包括高CRP和低KT/V。透析不充分是慢性HD儿童EPO抵抗的最重要危险因素。充分透析被认为是预防EPO抵抗的一项保护措施。

相似文献

1
Erythropoietin resistance among pediatric patients on chronic hemodialysis: A cross-sectional study.慢性血液透析患儿的促红细胞生成素抵抗:一项横断面研究。
Pediatr Nephrol. 2025 Apr 28. doi: 10.1007/s00467-025-06776-4.
2
Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients.急性期反应可预测血液透析和腹膜透析患者对促红细胞生成素的抵抗。
Am J Kidney Dis. 1999 Jan;33(1):63-72. doi: 10.1016/s0272-6386(99)70259-3.
3
Hemodialysis treatment time versus erythropoietin dose requirement: Reduction in 2,000 units per week by extension of hemodialysis for 1 hour
.血液透析治疗时间与促红细胞生成素剂量需求的关系:每周血液透析时间延长1小时可使促红细胞生成素剂量需求减少2000单位 。
Clin Nephrol. 2019 Oct;92(4):174-179. doi: 10.5414/CN109403.
4
Iron Indices Mediate but Not Modify Association of Parathyroid Hormone with Erythropoietin Resistance in Hemodialysis Patients.铁指标介导但不能修饰甲状旁腺激素与血液透析患者红细胞生成素抵抗的关系。
Blood Purif. 2024;53(7):583-590. doi: 10.1159/000539080. Epub 2024 May 6.
5
Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis.慢性血液透析患者对重组人促红细胞生成素的依赖性:临床特征、铁稳态与红细胞生成
Clin Nephrol. 2005 Feb;63(2):92-7. doi: 10.5414/cnp63092.
6
Neutrophil-to-Lymphocyte Ratio and Erythropoietin Resistance among Maintenance Hemodialysis Patients.维持性血液透析患者中性粒细胞与淋巴细胞比值和红细胞生成素抵抗。
Blood Purif. 2022;51(8):708-713. doi: 10.1159/000519644. Epub 2021 Oct 14.
7
Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality.血液透析患者中影响促红细胞生成素反应的因素及其与死亡率的关系。
Kidney Int Suppl. 2008 Dec(111):S75-81. doi: 10.1038/ki.2008.523.
8
Association of gender and age with erythropoietin resistance in hemodialysis patients: role of menstrual status.血液透析患者中性别和年龄与促红细胞生成素抵抗的关联:月经状态的作用
Blood Purif. 2004;22(5):423-7. doi: 10.1159/000080234. Epub 2004 Aug 13.
9
Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.促红细胞生成素需求:腹膜透析与血液透析的多中心比较研究
J Nephrol. 2003 Sep-Oct;16(5):697-702.
10
C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients.C反应蛋白而非铁调素、中性粒细胞明胶酶相关脂质运载蛋白和转铁蛋白决定了血液透析患者对促红细胞生成素的抵抗。
Ren Fail. 2016;38(1):89-95. doi: 10.3109/0886022X.2015.1106896. Epub 2015 Nov 5.

引用本文的文献

1
Comment on: Erythropoietin resistance among pediatric patients on chronic hemodialysis: A cross-sectional study.关于《慢性血液透析患儿的促红细胞生成素抵抗:一项横断面研究》的评论
Pediatr Nephrol. 2025 May 26. doi: 10.1007/s00467-025-06835-w.

本文引用的文献

1
The Relationship between Parents' Use of the Pediatric Emergency Department and Cyberchondria.父母使用儿科急诊科与网络疑病症之间的关系。
Clin Pediatr (Phila). 2025 Jul;64(7):996-1006. doi: 10.1177/00099228241308006. Epub 2024 Dec 22.
2
Neutrophil-to-Lymphocyte Ratio and Erythropoietin Resistance among Maintenance Hemodialysis Patients.维持性血液透析患者中性粒细胞与淋巴细胞比值和红细胞生成素抵抗。
Blood Purif. 2022;51(8):708-713. doi: 10.1159/000519644. Epub 2021 Oct 14.
3
Managing Anemia across the Stages of Kidney Disease in Those Hyporesponsive to Erythropoiesis-Stimulating Agents.
管理对红细胞生成刺激剂低反应性的慢性肾脏病各期患者的贫血
Am J Nephrol. 2021;52(6):450-466. doi: 10.1159/000516901. Epub 2021 Jul 19.
4
Erythropoietin Resistance Index and the Affecting Factors in Children with Peritoneal Dialysis.红细胞生成素抵抗指数及其对腹膜透析患儿的影响因素。
Blood Purif. 2021;50(6):942-951. doi: 10.1159/000514060. Epub 2021 Mar 30.
5
High Erythropoiesis Resistance Index Is a Significant Predictor of Cardiovascular and All-Cause Mortality in Chinese Maintenance Hemodialysis Patients.高红细胞生成抵抗指数是中国维持性血液透析患者心血管和全因死亡率的重要预测指标。
Mediators Inflamm. 2020 Nov 26;2020:1027230. doi: 10.1155/2020/1027230. eCollection 2020.
6
Platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios as markers of erythropoietin resistance in chronic haemodialysis patients: a multicentre cross-sectional study.血小板与淋巴细胞比值和中性粒细胞与淋巴细胞比值作为慢性血液透析患者红细胞生成素抵抗的标志物:一项多中心横断面研究。
Nefrologia (Engl Ed). 2020 May-Jun;40(3):320-327. doi: 10.1016/j.nefro.2019.09.007. Epub 2019 Dec 12.
7
Hemodialysis treatment time versus erythropoietin dose requirement: Reduction in 2,000 units per week by extension of hemodialysis for 1 hour
.血液透析治疗时间与促红细胞生成素剂量需求的关系:每周血液透析时间延长1小时可使促红细胞生成素剂量需求减少2000单位 。
Clin Nephrol. 2019 Oct;92(4):174-179. doi: 10.5414/CN109403.
8
Anemia of inflammation.炎症性贫血。
Blood. 2019 Jan 3;133(1):40-50. doi: 10.1182/blood-2018-06-856500. Epub 2018 Nov 6.
9
Association of Neutrophil-to-Lymphocyte Ratio With Inflammation and Erythropoietin Resistance in Chronic Dialysis Patients.慢性透析患者中性粒细胞与淋巴细胞比值与炎症及促红细胞生成素抵抗的相关性
Can J Kidney Health Dis. 2017 Nov 3;4:2054358117735563. doi: 10.1177/2054358117735563. eCollection 2017.
10
[Clinical management of anemia in patients with CKD].[慢性肾脏病患者贫血的临床管理]
G Ital Nefrol. 2017 Mar;34(Suppl 69):20-35.